|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.12 SEK | -33.33% |
|
-2.44% | -49.58% |
| May. 13 | Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Hemcheck Sweden AB (publ) received a first small order from the university hospital Charité in Berlin. The order concerns bgs-Test and is of lower economic value. It is very positive with a first order from Charité.
The hospital is a very large university hospital and a reference hospital for many other possible customers both in Germany and internationally.
| 1st Jan change | Capi. | |
|---|---|---|
| -49.58% | 5.02M | |
| +99.39% | 7.36B | |
| -21.23% | 6.62B | |
| +7.89% | 5.73B | |
| -22.19% | 3.46B | |
| +6.24% | 2.5B | |
| +35.32% | 2.28B | |
| -7.91% | 2.22B | |
| -69.64% | 1.88B | |
| -18.50% | 1.57B |
BIO VITOS PHARMA AB 
